SMIP004 50mg 50mg | Purity Not Available
Adooq Bioscience
SMIP004 is a novel inducer of cancer-cell selective apoptosis of human prostate cancer cells.
More Information Supplier PageSearch Results
SMIP004 5mg 5mg | Purity Not Available
Adooq Bioscience
SMIP004 is a novel inducer of cancer-cell selective apoptosis of human prostate cancer cells.
More Information Supplier PageSMIP004 10mg 10mg | Purity Not Available
Adooq Bioscience
SMIP004 is a novel inducer of cancer-cell selective apoptosis of human prostate cancer cells.
More Information Supplier PageSLx-2119 5mg 5mg | Purity Not Available
Adooq Bioscience
SLx-2119 is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM; > 200 fold selecivity over ROCK1(IC50 =24 uM).
More Information Supplier PageSLx-2119 100mg 100mg | Purity Not Available
Adooq Bioscience
SLx-2119 is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM; > 200 fold selecivity over ROCK1(IC50 =24 uM).
More Information Supplier PageSLx-2119 10mg 10mg | Purity Not Available
Adooq Bioscience
SLx-2119 is a small molecule and selective inhibitor of ROCK2 with IC50 of 105 nM; > 200 fold selecivity over ROCK1(IC50 =24 uM).
More Information Supplier PageSJB2-043 50mg 50mg | Purity Not Available
Adooq Bioscience
SJB2-043 is one of analogs/derivatives of C527, which is a novel and potent USP1 (ubiquitin-specific protease 1) inhibitor.
More Information Supplier PageSJB2-043 5mg 5mg | Purity Not Available
Adooq Bioscience
SJB2-043 is one of analogs/derivatives of C527, which is a novel and potent USP1 (ubiquitin-specific protease 1) inhibitor.
More Information Supplier Page